In the Phase 2 obesity trial, gastrointestinal adverse events were the most common and were dose related. The paper also described changes in heart rate during follow-up.
Reading adverse events by arm
Tolerability tables give context for weight outcomes by showing who experienced an event or discontinued treatment. Compare the event definition and denominator before drawing conclusions from percentages.
How to interpret the evidence
Read the event tables and methods alongside any dose-response figure. Trial monitoring and eligibility shape which events are observed.
This series reports assigned research arms for interpreting study results. Retatrutide is investigational, and clinical-trial amounts are not dosing instructions.